3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
15
Neoplasm Metastasis
11
Ovarian Neoplasms
9
Pancreatic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Stomach Neoplasms
6
Skin Neoplasms
6
Leukemia, Myeloid, Acute
6
Colorectal Neoplasms
6
Carcinoma, Renal Cell
6
Triple Negative Breast Neoplasms
4
Gastrointestinal Neoplasms
4
Breast Neoplasms
4
Vulvar Neoplasms
3
Uterine Cervical Neoplasms
3
Urogenital Neoplasms
3
Rectal Neoplasms
3
Neuroblastoma
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Leukemia
3
Colonic Neoplasms
3
Vaginal Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pleural Effusion, Malignant
2
Penile Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Interventions
Cyclophosphamide
15
fludarabine phosphate
11
fludarabine
11
Whole-Body Irradiation
11
Mycophenolic Acid
11
Busulfan
9
Melphalan
8
Tacrolimus
7
Peripheral Blood Stem Cell Transplantation
7
Granulocyte Colony-Stimulating Factor
5
Cyclosporine
5
Azacitidine
5
Filgrastim
4
venetoclax
3
Cord Blood Stem Cell Transplantation
3
Biopsy
3
thymoglobulin
2
decitabine and cedazuridine drug combination
2
Vorinostat
2
Thiotepa
2
Specimen Handling
2
Sirolimus
2
Rituximab
2
Methotrexate
2
Injections
2
Hematopoietic Stem Cell Transplantation
2
Etoposide
2
Cytarabine
2
Cyclosporins
2
Clofarabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anemia, Refractory, with Excess of Blasts
×
aldesleukin
×
1 year
×
Clear all
No trials found.